281 related articles for article (PubMed ID: 34838620)
1. Improving the solubility of vorinostat using cyclodextrin inclusion complexes: The physicochemical characteristics, corneal permeability and ocular pharmacokinetics of the drug after topical application.
Yang J; Ma Y; Luo Q; Liang Z; Lu P; Song F; Zhang Z; Zhou T; Zhang J
Eur J Pharm Sci; 2022 Jan; 168():106078. PubMed ID: 34838620
[TBL] [Abstract][Full Text] [Related]
2. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization.
Yousaf AM; Qadeer A; Raza SA; Chohan TA; Shahzad Y; Din FU; Khan IU; Hussain T; Alvi MN; Mahmood T
Polim Med; 2019; 49(1):35-43. PubMed ID: 31769938
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization, and antifungal property of the inclusion complex of Litsea cubeba essential oil/hydroxypropyl-β-cyclodextrin and its application in preservation of Shatang mandarin.
Li X; Li G; Shan Y; Zhu X
J Food Sci; 2022 Oct; 87(10):4714-4724. PubMed ID: 36121061
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
5. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.
Williams RO; Mahaguna V; Sriwongjanya M
Eur J Pharm Biopharm; 1998 Nov; 46(3):355-60. PubMed ID: 9885309
[TBL] [Abstract][Full Text] [Related]
7. Formulation of Apigenin-Cyclodextrin-Chitosan Ternary Complex: Physicochemical Characterization, In Vitro and In Vivo Studies.
Jafar M; Khalid MS; Alghamdi H; Amir M; Al Makki SA; Alotaibi OS; Al Rmais AA; Imam SS; Alshehri S; Gilani SJ
AAPS PharmSciTech; 2022 Feb; 23(2):71. PubMed ID: 35146576
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
Sathigari S; Chadha G; Lee YH; Wright N; Parsons DL; Rangari VK; Fasina O; Babu RJ
AAPS PharmSciTech; 2009; 10(1):81-7. PubMed ID: 19148759
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-mediated molecular self-assemble of thymol with 2-hydroxypropyl-β-cyclodextrin for fruit preservation.
Sun C; Cao J; Wang Y; Chen J; Huang L; Zhang H; Wu J; Sun C
Food Chem; 2021 Nov; 363():130327. PubMed ID: 34144424
[TBL] [Abstract][Full Text] [Related]
10. Intracorneal melatonin delivery using 2-hydroxypropyl-β-cyclodextrin ophthalmic solution for granular corneal dystrophy type 2.
Ahn JH; Kim HD; Abuzar SM; Lee JY; Jin SE; Kim EK; Hwang SJ
Int J Pharm; 2017 Aug; 529(1-2):608-616. PubMed ID: 28694094
[TBL] [Abstract][Full Text] [Related]
11. An ocular drug delivery system containing zinc diethyldithiocarbamate and HPbetaCD inclusion complex--corneal permeability, anti-cataract effects and mechanism studies.
Wang S; Li D; Ito Y; Liu X; Zhang J; Wu C
J Pharm Pharmacol; 2004 Oct; 56(10):1251-7. PubMed ID: 15482639
[TBL] [Abstract][Full Text] [Related]
12. Dihydroartemisinin-cyclodextrin complexation: solubility and stability.
Ansari MT; Iqbal I; Sunderland VB
Arch Pharm Res; 2009 Jan; 32(1):155-65. PubMed ID: 19183889
[TBL] [Abstract][Full Text] [Related]
13. The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes.
Jambhekar S; Casella R; Maher T
Int J Pharm; 2004 Feb; 270(1-2):149-66. PubMed ID: 14726131
[TBL] [Abstract][Full Text] [Related]
14. Solubility, Permeability, Anti-Inflammatory Action and In Vivo Pharmacokinetic Properties of Several Mechanochemically Obtained Pharmaceutical Solid Dispersions of Nimesulide.
Wei W; Evseenko VI; Khvostov MV; Borisov SA; Tolstikova TG; Polyakov NE; Dushkin AV; Xu W; Min L; Su W
Molecules; 2021 Mar; 26(6):. PubMed ID: 33802031
[TBL] [Abstract][Full Text] [Related]
15. Improvement in Solubility-Permeability Interplay of Psoralens from
Machado RD; Silva JCG; Silva LAD; Oliveira GAR; Lião LM; Lima EM; de Morais MC; da Conceição EC; Rezende KR
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889459
[TBL] [Abstract][Full Text] [Related]
16. Complexation study of the anticancer agent EO-9 with 2-hydroxypropyl-beta-cyclodextrin.
Beijnen JH; van der Schoot SC; Nuijen B; Flesch FM; Gore A; Mirejovsky D; Lenaz L
Drug Dev Ind Pharm; 2008 Oct; 34(10):1130-9. PubMed ID: 18663657
[TBL] [Abstract][Full Text] [Related]
17. Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin.
Echezarreta-López M; Torres-Labandeira JJ; Castiñeiras-Seijo L; Santana-Penín L; Vila-Jato JL
Eur J Pharm Sci; 2000 Feb; 9(4):381-6. PubMed ID: 10664478
[TBL] [Abstract][Full Text] [Related]
18. Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir.
Tirucherai GS; Mitra AK
AAPS PharmSciTech; 2003; 4(3):E45. PubMed ID: 14621977
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W
Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753
[TBL] [Abstract][Full Text] [Related]
20. Release Characteristics of an Essential Oil Component Encapsulated with Cyclodextrin Shell Matrices.
Li Z; Wen W; Chen X; Zhu L; Cheng G; Liao Z; Huang H; Ming L
Curr Drug Deliv; 2021; 18(4):487-499. PubMed ID: 32735520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
